Percutaneous Coronary Intervention Associated with a Higher Risk of Hypoxemia and COVID-19 Severity

  • Авторы: Shayan S.1, Nasrollahi E.2, Bahramvand Y.2, Zarei M.3, Atarodi A.4, Farsi Y.5, Tavakolizadeh M.6, Shirvaliloo M.7, Abbasifard M.8, Jamialahmadi T.9, Banach M.10, Sahebkar A.11
  • Учреждения:
    1. Clinical Research Development Unit, Bohlool Hospital, Gonabad University of Medical Sciences
    2. School of Medicine, Shiraz University of Medical Sciences
    3. Student Research Committee, Tabriz University of Medical Sciences
    4. tudent Research Committee, School of Medicine, Gonabad University of Medical Sciences
    5. Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences
    6. Clinical Research Development Unit, Gonabad University of Medical Sciences
    7. Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences
    8. Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences
    9. Surgical Oncology Research Center, Mashhad University of Medical Sciences
    10. Department of Preventive Cardiology and Lipidology, Chair of Nephrology and Hypertension, Medical University of Lodz,
    11. Applied Biomedical Research Center, Mashhad University of Medical Sciences
  • Выпуск: Том 31, № 10 (2024)
  • Страницы: 1265-1277
  • Раздел: Anti-Infectives and Infectious Diseases
  • URL: https://cijournal.ru/0929-8673/article/view/644156
  • DOI: https://doi.org/10.2174/0929867330666230222104345
  • ID: 644156

Цитировать

Полный текст

Аннотация

Objective:The primary goal of the present study was to measure the implications of hypoxemia in COVID-19 patients with a history of coronary artery disease (CAD).

Methods:A systematic search of the literature published from November 1, 2019 to May 1, 2021, was conducted on PubMed/MEDLINE, Embase, and Web of Science databases. Afterwards, an observational study was designed based on the electronic health records of COVID-19 patients hospitalized in a tertiary referral hospital during the same period. A total of 179 COVID-19 cases were divided into two groups: cases with a history of CAD and percutaneous coronary intervention (CAD/PCI+, n = 89) and controls (n = 90). Clinical data were extracted from the electronic database of the hospital and statistically analyzed.

Results:After the application of inclusion/exclusion criteria, only three studies were deemed eligible, one of which was concerned with the impact of CAD on the all-cause mortality of COVID-19. Results from our observational study indicated that the cases were older (median age: 74 vs. 45) and more likely to develop hypoxemia (25.8% vs. 8.8%) than the controls. CAD/PCI+ was correlated with a more severe COVID-19 (11% vs. 1%). Age was a moderately significant independent predictor of increased COVID-19 severity, while hypoxemia was not.

Conclusion:Considering the negative impact of hypoxemia on the prognosis of COVID-19 and its higher prevalence among COVID-19 patients with underlying CAD, further research is warranted to unravel the negative effects of COVID-19 on the mechanisms of gas exchange and delivery in patients with pre-existing CAD.

Об авторах

Sepideh Shayan

Clinical Research Development Unit, Bohlool Hospital, Gonabad University of Medical Sciences

Email: info@benthamscience.net

Elham Nasrollahi

School of Medicine, Shiraz University of Medical Sciences

Email: info@benthamscience.net

Yaser Bahramvand

School of Medicine, Shiraz University of Medical Sciences

Email: info@benthamscience.net

Mahdi Zarei

Student Research Committee, Tabriz University of Medical Sciences

Email: info@benthamscience.net

Ahmadreza Atarodi

tudent Research Committee, School of Medicine, Gonabad University of Medical Sciences

Email: info@benthamscience.net

Yeganeh Farsi

Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences

Email: info@benthamscience.net

Mitra Tavakolizadeh

Clinical Research Development Unit, Gonabad University of Medical Sciences

Email: info@benthamscience.net

Milad Shirvaliloo

Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences

Email: info@benthamscience.net

Mitra Abbasifard

Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences

Email: info@benthamscience.net

Tannaz Jamialahmadi

Surgical Oncology Research Center, Mashhad University of Medical Sciences

Email: info@benthamscience.net

Maciej Banach

Department of Preventive Cardiology and Lipidology, Chair of Nephrology and Hypertension, Medical University of Lodz,

Email: info@benthamscience.net

Amirhossein Sahebkar

Applied Biomedical Research Center, Mashhad University of Medical Sciences

Автор, ответственный за переписку.
Email: info@benthamscience.net

Список литературы

  1. Amini, M.; Zayeri, F.; Salehi, M. Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: Results from global burden of disease study 2017. BMC Public Health, 2021, 21(1), 401. doi: 10.1186/s12889-021-10429-0 PMID: 33632204
  2. Olvera Lopez, E; Ballard, BD; Jan, A Cardiovascular Disease; StatPearls Publishing: Treasure Island, 2021.
  3. Bae, S.; Kim, S.R.; Kim, M.N.; Shim, W.J.; Park, S.M. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart, 2021, 107(5), 373-380. doi: 10.1136/heartjnl-2020-317901 PMID: 33334865
  4. Zibaeenezhad, M.J.; Sayadi, M.; Bazrafshan, H. The prevalence of cardiovascular risk factors in fatal cases of COVID-19 in Fars province, Iran. Int. Cardiovasc. Res. J., 2021, 15, 35-39.
  5. Brouqui, P.; Amrane, S.; Million, M.; Cortaredona, S.; Parola, P.; Lagier, J.C.; Raoult, D. Asymptomatic hypoxia in COVID-19 is associated with poor outcome. Int. J. Infect. Dis., 2021, 102, 233-238. doi: 10.1016/j.ijid.2020.10.067 PMID: 33130200
  6. Okuhama, A.; Ishikane, M.; Hotta, M.; Sato, L.; Akiyama, Y.; Morioka, S.; Suzuki, S.; Tajima, T.; Yamamoto, M.; Teruya, K.; Izumi, S.; Ohmagari, N. Clinical and radiological findings of silent hypoxia among COVID-19 patients. J. Infect. Chemother., 2021, 27(10), 1536-1538. doi: 10.1016/j.jiac.2021.07.002 PMID: 34294527
  7. García-Grimshaw, M.; Flores-Silva, F.D.; Chiquete, E.; Cantú-Brito, C.; Michel-Chávez, A.; Vigueras-Hernández, A.P.; Domínguez-Moreno, R.; Chávez-Martínez, O.A.; Sánchez-Torres, S.; Marché-Fernández, O.A.; González-Duarte, A. Characteristics and predictors for silent hypoxemia in a cohort of hospitalized COVID-19 patients. Auton. Neurosci., 2021, 235, 102855. doi: 10.1016/j.autneu.2021.102855 PMID: 34293703
  8. Wang, J.G.; Liu, B.; Percha, B.; Pan, S.; Goel, N.; Mathews, K.S.; Gao, C.; Tandon, P.; Tomlinson, M.; Yoo, E.; Howell, D.; Eisenberg, E.; Naymagon, L.; Tremblay, D.; Chokshi, K.; Dua, S.; Dunn, A.S.; Powell, C.A.; Bose, S. Cardiovascular disease and severe hypoxemia are associated with higher rates of noninvasive respiratory support failure in Coronavirus Disease 2019 Pneumonia. Crit. Care Explor., 2021, 3(3), e0355. doi: 10.1097/CCE.0000000000000355 PMID: 33655216
  9. Wang, R.S.; Oldham, W.M.; Loscalzo, J. Network-based association of hypoxia-responsive genes with cardiovascular diseases. New J. Phys., 2014, 16(10), 105014. doi: 10.1088/1367-2630/16/10/105014 PMID: 25530704
  10. Nikoo, M.H.; Mozaffari, R.; Hatamnejad, M.R.; Bazrafshan, M.; Kasaei, M.; Bazrafshan, H. Systolic dysfunction and complete heart block as complications of fulminant myocarditis in a recovered COVID-19 patient. J. Cardiol. Cases, 2021, 24(4), 177-181. doi: 10.1016/j.jccase.2021.03.009 PMID: 33897917
  11. Fokkema, M.L.; James, S.K.; Albertsson, P.; Aasa, M.; Åkerblom, A.; Calais, F.; Eriksson, P.; Jensen, J.; Schersten, F.; de Smet, B.J.; Sjögren, I.; Tornvall, P.; Lagerqvist, B. Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). EuroIntervention, 2016, 12(3), 303-311. doi: 10.4244/EIJY15M10_07 PMID: 26485732
  12. Xu, J.; Teng, Y.; Shang, L.; Gu, X.; Fan, G.; Chen, Y.; Tian, R.; Zhang, S.; Cao, B. The effect of prior angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment on coronavirus disease 2019 (COVID-19) susceptibility and outcome: A systematic review and meta-analysis. Clin. Infect. Dis., 2021, 72(11), e901-e913. doi: 10.1093/cid/ciaa1592 PMID: 33079200
  13. Ghaferi, A.A.; Schwartz, T.A.; Pawlik, T.M. STROBE reporting guidelines for observational studies. JAMA Surg., 2021, 156(6), 577-578. doi: 10.1001/jamasurg.2021.0528 PMID: 33825815
  14. Love, J.; Selker, R.; Marsman, M.; Jamil, T.; Dropmann, D.; Verhagen, J.; Ly, A.; Gronau, Q.F.; Smíra, M.; Epskamp, S.; Matzke, D.; Wild, A.; Knight, P.; Rouder, J.N.; Morey, R.D.; Wagenmakers, E-J. JASP: Graphical statistical software for common statistical designs. J. Stat. Softw., 2019, 88(2), 1-17. doi: 10.18637/jss.v088.i02
  15. Lew, M.J. A reckless guide to p-values. Handb. Exp. Pharmacol., 2019, 257, 223-256. doi: 10.1007/164_2019_286 PMID: 31897610
  16. Thiese, M.S.; Ronna, B.; Ott, U. P value interpretations and considerations. J. Thorac. Dis., 2016, 8(9), E928-E931. doi: 10.21037/jtd.2016.08.16 PMID: 27747028
  17. Haunschild, R. Mendeley. In: Handbook Bibliometrics; De Gruyter, 2020; pp. 281-287. doi: 10.1515/9783110646610-028
  18. Qin, C.; Zhou, L.; Hu, Z.; Yang, S.; Zhang, S.; Chen, M.; Yu, H.; Tian, D.S.; Wang, W. Clinical characteristics and outcomes of COVID-19 patients with a history of stroke in wuhan, China. Stroke, 2020, 51(7), 2219-2223. doi: 10.1161/STROKEAHA.120.030365 PMID: 32466735
  19. Kummer, B.R.; Klang, E.; Stein, L.K.; Dhamoon, M.S.; Jetté, N. History of stroke is independently associated with in-hospital death in patients with COVID-19. Stroke, 2020, 51(10), 3112-3114. doi: 10.1161/STROKEAHA.120.030685 PMID: 32772679
  20. Loffi, M.; Piccolo, R.; Regazzoni, V.; Di Tano, G.; Moschini, L.; Robba, D.; Quinzani, F.; Esposito, G.; Franzone, A.; Danzi, G.B. Coronary artery disease in patients hospitalised with coronavirus disease 2019 (COVID-19) infection. Open Heart, 2020, 7(2), e001428. doi: 10.1136/openhrt-2020-001428 PMID: 33229434
  21. Antza, C.; Doundoulakis, I.; Stabouli, S.; Kotsis, V. American, European and international hypertension guidelines: Time to shake hands? Int. Cardiol. Hypertens., 2021, 8, 100075. doi: 10.1016/j.ijchy.2020.100075 PMID: 33884368
  22. Silverio, A.; Di Maio, M.; Citro, R.; Esposito, L.; Iuliano, G.; Bellino, M.; Baldi, C.; De Luca, G.; Ciccarelli, M.; Vecchione, C.; Galasso, G. Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients. BMC Cardiovasc. Disord., 2021, 21(1), 23. doi: 10.1186/s12872-020-01816-3 PMID: 33413093
  23. Shoar, S.; Hosseini, F.; Naderan, M.; Mehta, J.L. Meta- analysis of cardiovascular events and related biomarkers comparing survivors versus non-survivors in patients with COVID-19. Am. J. Cardiol., 2020, 135, 50-61. doi: 10.1016/j.amjcard.2020.08.044 PMID: 32916148
  24. Kollias, A.; Kyriakoulis, K.G.; Kyriakoulis, I.G.; Nitsotolis, T.; Poulakou, G.; Stergiou, G.S.; Syrigos, K. Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis. Atherosclerosis, 2021, 330, 114-121. doi: 10.1016/j.atherosclerosis.2021.06.911 PMID: 34243953
  25. Ricci, M.A.; De Vuono, S.; Scavizzi, M.; Gentili, A.; Lupattelli, G. Facing morbid obesity: How to approach it. Angiology, 2016, 67(4), 391-397. doi: 10.1177/0003319715595735 PMID: 26187640

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© Bentham Science Publishers, 2024